Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
about
Identification of glycogen synthase kinase 3α as a therapeutic target in melanomaSynthetic lethality: emerging targets and opportunities in melanoma.Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyAurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy.Targeting multiple key signaling pathways in melanoma using leelamine.Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK ExpressionNanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism.Targeting protein kinase-b3 (akt3) signaling in melanoma.Moving synergistically acting drug combinations to the clinic by comparing sequential versus simultaneous drug administrations.Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.Kinase-targeted cancer therapies: progress, challenges and future directions.Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.
P2860
Q33569998-BA7E730D-56A0-48CF-8A91-DBD53320BFF3Q33578398-0FE3CB93-42DB-4AA8-A1A4-5F268AEB09D4Q33709666-B3D51D0D-7A5C-426A-B2D7-5CFABA102866Q33859472-E8FE05ED-EBDD-4550-91C9-0DB1598CB945Q35041273-25B1027E-B5D3-43FA-8260-49DA49887ADEQ35136450-107BC635-A66A-42A1-83E9-A9E82733F531Q35217023-901A3B3D-A6F2-438A-8F9C-2804C1CB8167Q35691278-5EEBF634-5E24-4BF2-86B1-AA625822F2D2Q38724921-441054EE-9ECC-4B52-9693-71AF4667EA66Q38979464-8125E4D1-16F3-4685-B5AE-BBF038057960Q39074281-DB53F79D-8C16-469E-8A6F-87AF946A343EQ47292160-BAC58B84-714D-436B-BA09-4FE2E16B3A3DQ48155250-4159D979-9AA9-4F82-ADD7-2CE9D114E60EQ49887882-E76A0A2A-F85D-4E3B-AD8D-1EEC25A13850Q50113740-A4A6F379-1AC5-464C-B9FD-2C607187CF5A
P2860
Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of aurora kinas ...... s of (V600E)B-RAF in melanoma.
@en
type
label
Identification of aurora kinas ...... s of (V600E)B-RAF in melanoma.
@en
prefLabel
Identification of aurora kinas ...... s of (V600E)B-RAF in melanoma.
@en
P2093
P2860
P1476
Identification of aurora kinas ...... s of (V600E)B-RAF in melanoma.
@en
P2093
Arati Sharma
Arthur Berg
Gavin P Robertson
Raghavendra Gowda
Rogerio I Neves
SubbaRao V Madhunapantula
P2860
P304
P356
10.1016/J.AJPATH.2012.12.019
P407
P577
2013-02-12T00:00:00Z